Tongling Jieya Biologic Technology Co., Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 344.06 million compared to CNY 620.52 million a year ago. Revenue was CNY 359.55 million compared to CNY 626.57 million a year ago.

Net income was CNY 89.16 million compared to CNY 137.18 million a year ago. Basic earnings per share from continuing operations was CNY 1.1 compared to CNY 2.25 a year ago. Diluted earnings per share from continuing operations was CNY 1.1 compared to CNY 2.25 a year ago.